Efficacy of Paclitaxel-based Chemotherapy After Progression on Nivolumab for Head and Neck Cancer

Background/Aim: In the CheckMate-141 trial regarding head and neck cancer (HNC), nivolumab conferred a survival benefit to patients. However, the best treatment sequence of chemotherapy and anti-PD-1/PD-L1 therapy in these cancers is unclear. Patients and Methods: This was an observational study usi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:In Vivo
Main Authors: SATO, YASUYOSHI, FUKUDA, NAOKI, FUJIWARA, YU, WANG, XIAOFEI, URASAKI, TETSUYA, OHMOTO, AKIHIRO, NAKANO, KENJI, ONO, MAKIKO, TOMOMATSU, JUNICHI, MITANI, HIROKI, TAKAHASHI, SHUNJI
Formato: Artigo
Idioma:Inglês
Publicado em: International Institute of Anticancer Research 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8045096/
https://ncbi.nlm.nih.gov/pubmed/33622923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12371
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados